Skip to main content

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings

Shares (Q2 2026)
84,212
Value
$309.1K
% of portfolio
<0.1%
Quarters held
20
Since Q2 2021
Holdings of RXRX by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202684,212$309.1K<0.1%−5,581−6.2%ReducedHolders
Q1 202689,793$275.7K<0.1%−2,449−2.7%ReducedHolders
Q4 202592,242$377.3K<0.1%+14,303+18.4%AddedHolders
Q3 202577,939$380.3K<0.1%−6,614−7.8%ReducedHolders
Q2 202584,553$427.8K<0.1%+12,300+17.0%AddedHolders
Q1 202572,253$382.2K<0.1%−15,905−18.0%ReducedHolders
Q4 202488,158$595.9K<0.1%+26,847+43.8%AddedHolders
Q3 202461,311$404.0K<0.1%+28,434+86.5%AddedHolders
Q2 202432,877$246.6K<0.1%−8,072−19.7%ReducedHolders
Q1 202440,949$408.3K<0.1%+5,051+14.1%AddedHolders
Q4 202335,898$354.0K<0.1%+4,829+15.5%AddedHolders
Q3 202331,069$237.7K<0.1%+1,372+4.6%AddedHolders
Q2 202329,697$221.8K<0.1%+895+3.1%AddedHolders
Q1 202328,802$192.1K<0.1%−3,809−11.7%ReducedHolders
Q4 202232,611$251.4K<0.1%+3,707+12.8%AddedHolders
Q3 202228,904$308.0K<0.1%+954+3.4%AddedHolders
Q2 202227,950$227.0K<0.1%−10,157−26.7%ReducedHolders
Q1 202238,107$272.0K<0.1%−9,542−20.0%ReducedHolders
Q4 202147,649$816.0K<0.1%+47,649NewHolders
Q3 20210$00.0%−5,482−100.0%Sold outHolders
Q2 20215,482$200.0K<0.1%+5,482NewHolders